Clinical Trials Search Results | Moffitt

Disease Site

Keyword

Study Type

Medication

Therapy

Principal Investigator

NCT#

Study Phase

1

2

3

4

311 Clinical Trials Found

Order By

Clinical Trial 20767

Integration of Immunotherapy into Adjuvant Therapy For Resected NSCLC: Alchemist Chemo-IO

Disease Site: Lung, Non small cell lung cancer

PI: Gray, Jhanelle

Clinical Trial 22086

A Phase II Study of CART-ddBCMA for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

Disease Site: Multiple Myeloma

PI: Freeman, Ciara

Clinical Trial 20794

Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma: Safety and Biomarker Analysis

Disease Site: Merkel cell carcinoma, Other Skin

PI: Tarhini, Ahmad

Clinical Trial 22695

Disease Site: Soft Tissue

PI: Druta, Mihaela

Clinical Trial 21917

A Phase II Study Of Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Overexpressing Gastroesophageal Cancers

Disease Site: Other

PI: Mehta, Rutika

Clinical Trial 22318

Disease Site: Other

PI: Kuykendall, Andrew

Clinical Trial 22685

Phase 1/1B, Multicenter, Open-Label, Study of RMC-9805 in Participants with Advanced KRASG12D-Mutant Solid Tumors

Disease Site: Any Site, Esophagus, Liver, Lung, Other Digestive Organ, Pancreas, Small Intestine, Stomach

PI: Kim, Dae Won

Clinical Trial 21135

Randomized, Placebo-Controlled, Phase II Trial Examining Ustekinumab for Prevention of Graft vs. Host Disease after Allogeneic Hematopoietic Cell Transplantation

Disease Site: Unknown Sites

PI: Pidala, Joseph

Clinical Trial 21636

A Dose-Escalation and Expansion Study of the Safety and Efficacy of XL092 in Combination with Immuno-Oncology Agents in Subjects with Unresectable Advanced or Metastatic Solid Tumors

Disease Site: Breast, Colon, Prostate, Urinary Bladder

PI: Chahoud, Jad

Clinical Trial 20026

A Phase I Study of NBTXR3 Activated by Radiotherapy for Patients with Advanced Cancers Treated with an Anti-PD1 Therapy

Disease Site: Lung

PI: Yang, George

Clinical Trial 22005

A Phase 2 Open-Label, Multicenter Study of Rituximab and Zanubrutinib in Patients with indolent B-cell Lymphomas

Disease Site: Other

PI: Gaballa, Sameh

Clinical Trial 19441

Pilot Study of Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma

Disease Site: Melanoma, skin

PI: Eroglu, Zeynep

Previous
1
...
8
9
10
11
12
13
14
...
26
Next